Design, Optimization, and Test Methods for Micro-Electrode-Dot-Array Digital Microfluidic Biochips

Digital microfluidic biochips (DMFBs) are revolutionizing many biochemical analysis procedures, e.g., high-throughput DNA sequencing and point-of-care clinical diagnosis. However, today’s DMFBs suffer from several limitations: (1) constraints on droplet size and the inability to vary droplet volume in a fine-grained manner; (2) the lack of integrated sensors for real-time detection; (3) the need for special fabrication processes and the associated reliability/yield concerns. To overcome the above limitations, DMFBs based on a micro-electrode-dot-array (MEDA) architecture have recently been proposed. Unlike conventional digital microfluidics, where electrodes of equal size are arranged in a regular pattern, the MEDA architecture is based on the concept of a sea-ofmicro-electrodes. The MEDA architecture allows microelectrodes to be dynamically grouped to form a micro-component that can perform different microfluidic operations on the chip. Design-automation tools can reduce the difficulty of MEDA biochip design and help to ensure that the manufactured biochips are versatile and reliable. In order to fully exploit MEDA-specific advantages (e.g., real-time droplet sensing), this dissertation research targets new design, optimization, and test problems for MEDA biochips.